Eric A. Adams serves as Executive at InMed Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Eric A. Adams has executed 5 insider transactions totaling $70.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 20, 2024 involved purchasing 41,600 shares valued at $15.0K.
Eric A. Adams currently holds 43,959 shares of InMed Pharmaceuticals Inc. (INM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric A. Adams has been a net buyer of INM stock. They have purchased $70.0K and sold $0 worth of shares.
Eric A. Adams's most recent insider trade was on Feb 20, 2024, when they purchased 41,600 shares at $0.36 per share.
Get notified when new Form 4 filings are submitted
| $0.89 |
| Discretionary |
| Apr 13, 2022 | INM | $7.3K | Purchase | 8,560 | $0.85 | Discretionary |
| Sep 29, 2021 | INM | $15.2K | Purchase | 8,800 | $1.73 | Discretionary |
| Sep 28, 2021 | INM | $19.9K | Purchase | 11,400 | $1.75 | Discretionary |